Laboratory diagnosis of Lyme neuroborreliosis: A comparison of three CSF anti-Borrelia antibody assays

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 5, 2014, Pages 797-803

  Henningsson, A J ^a   Christiansson, M ^a   Tjernberg, I ^b   Lofgren S ^a   Matussek, A ^a  

^a RYHOV COUNTY HOSPITAL   (Sweden)

^b KALMAR COUNTY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BORRELIA ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN;

ADULT; ARTICLE; BLOOD DONOR; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE DURATION; ELISA KIT; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TASK PERFORMANCE; ADOLESCENT; CHILD; COMPARATIVE STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC USE; EVALUATION STUDY; IMMUNOASSAY; IMMUNOLOGY; INFANT; LYME NEUROBORRELIOSIS; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CEREBROSPINAL FLUID; CHILD; CHILD, PRESCHOOL; CLINICAL LABORATORY TECHNIQUES; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; LYME NEUROBORRELIOSIS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 84900537262     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-2014-6     Document Type: Article

References (24)

1. Stanek G, Reiter M (2011) The expanding Lyme Borrelia complex-clinical significance of genomic species? Clin Microbiol Infect 17(4):487-493
2. Berglund J, Eitrem R, Ornstein K, Lindberg A, Ringér A, Elmrud H, Carlsson M, Runehagen A, Svanborg C, Norrby R (1995) An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 333(20):1319-1327
3. Weber K (2001) Aspects of Lyme borreliosis in Europe. Eur J Clin Microbiol Infect Dis 20(1):6-13
4. Stanek G, Strle F (2008) Lyme disease: European perspective. Infect Dis Clin North Am 22(2):327-339, vii
5. Strle F, Ruzić-Sabljić E, Cimperman J, Lotric-Furlan S, Maraspin V (2006) Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid. Clin Infect Dis 43(6):704-710 (Pubitemid 44330732)
6. Mygland A, Ljøstad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I; European Federation of Neurological Societies (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17(1):8-16, e1-4
7. Cerar T, Ogrinc K, Cimperman J, Lotric-Furlan S, Strle F, Ruzić-Sabljić E (2008) Validation of cultivation and PCR methods for diagnosis of Lyme neuroborreliosis. J Clin Microbiol 46(10):3375-3379
8. Karlsson M, Hovind-Hougen K, Svenungsson B, Stiernstedt G (1990) Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis. J Clin Microbiol 28(3):473-479 (Pubitemid 20078119)
9. Wilske B, Preac-Mursic V (1993) Microbiological diagnosis of Lyme borreliosis. In: Weber K, Burgdorfer W (eds) Aspects of Lyme borreliosis. Springer, Berlin Heidelberg New York, pp 267-299
10. Berglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H (2002) 5-y Follow-up study of patients with neuroborreliosis. Scand J Infect Dis 34(6):421-425 (Pubitemid 34823436)
11. Henningsson AJ, Malmvall BE, Ernerudh J, Matussek A, Forsberg P (2010) Neuroborreliosis - an epidemiological, clinical and healthcare cost study from an endemic area in the south-east of Sweden. Clin Microbiol Infect 16(8):1245-1251
12. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP (2005) Diagnosis of Lyme borreliosis. Clin Microbiol Rev 18(3):484-509 (Pubitemid 40995113)
13. Wilske B, Fingerle V, Schulte-Spechtel U (2007) Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol 49(1):13-21 (Pubitemid 46160581)
14. Hansen K, Lebech AM (1991) Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi-specific immunoglobulin G, A, and M. Ann Neurol 30(2):197-205
15. Peter JB (1990) Use and interpretation of tests in clinical immunology. Interstate Press, Omaha
16. Henningsson AJ, Tjernberg I, Malmvall BE, Forsberg P, Ernerudh J (2011) Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study. J Neuroinflammation 8:36
17. Tjernberg I, Henningsson AJ, Eliasson I, Forsberg P, Ernerudh J (2011) Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis. J Infect 62(2):149-158
18. Schmidt C, Plate A, Angele B, Pfister HW, Wick M, Koedel U, Rupprecht TA (2011) A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology 76(12):1051-1058
19. Ljøstad U, Mygland A (2008) CSF B - lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J Neurol 255(5):732-737
20. Tibbling G, Link H, Ohman S (1977) Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 37(5):385-390 (Pubitemid 8387871)
21. Kaiser R, Lücking CH (1993) Intrathecal synthesis of specific antibodies in neuroborreliosis. Comparison of different ELISA techniques and calculation methods. J Neurol Sci 118(1):64-72 (Pubitemid 23269968)
22. Reiber H, Peter JB (2001) Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 184(2):101-122 (Pubitemid 32178265)
23. Tjernberg I, Krüger G, Eliasson I (2007) C6 peptide ELISA test in the serodiagnosis of Lyme borreliosis in Sweden. Eur J Clin Microbiol Infect Dis 26(1):37-42 (Pubitemid 46089580)
24. Tumani H, Nölker G, Reiber H (1995) Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis. Neurology 45(9):1663-1670